Szabó Éva, Kopjár Eszter, Rumi László, Boronkai Árpád, Bellyei Szabolcs, Gyöngyi Zoltán, Zemplényi Antal, Sütő Balázs, Girán János, Kiss István, Pozsgai Éva, Szanyi István
Department of Otorhinolaryngology, Clinical Center, University of Pécs, Munkácsy M. Street 2., 7621 Pécs, Hungary.
Urology Clinic, Clinical Center, University of Pécs, Munkácsy Mihaly Street 2, 7621 Pécs, Hungary.
Cancers (Basel). 2024 Jul 18;16(14):2570. doi: 10.3390/cancers16142570.
The aim of our study was to compare the characteristics and time to initial physician contact in patients with head and neck squamous cell carcinoma (HNSCC) before and during the COVID-19 pandemic at a large Hungarian cancer center. This was a retrospective study of patients 18 years or older presenting at the regional cancer center of Pécs Clinical Center with HNSCC between 1 January 2017, and 15 March 2020 (the pre-COVID-19 period) and between 16 March 2020, and 13 May 2021 (the COVID-19 period). Demographic and clinical data were collected, and the time between initial symptom onset and initial physician contact (TTP) was determined. Descriptive and exploratory statistical analyses were performed. On average, the number of patients diagnosed with HNSCC per month during the pandemic decreased by 12.4% compared with the pre-COVID-19 period. There was a significant increase in stage I and stage II cancers (from 15.9% to 20.3% and from 12.2% to 13.8%, respectively; p < 0.001); a decrease in stage III and IVa,c cancers; and a significant increase in stage IVb cancers (from 6% to 19.9%; p < 0.001) during the pandemic. The median TTP increased during the pandemic from 43 to 61 days (p = 0.032). To our knowledge, this is the first study investigating the effect of COVID-19 on patients with HNSCC in the Central-Eastern European region. We found a bidirectional shift in cancer stages and increased TTP during the pandemic. Our findings highlight the necessity for more nuanced analyses of the effects of COVID-19.
我们研究的目的是比较在匈牙利一家大型癌症中心,2019冠状病毒病大流行之前和期间,头颈鳞状细胞癌(HNSCC)患者的特征以及首次联系医生的时间。这是一项回顾性研究,研究对象为2017年1月1日至2020年3月15日(2019冠状病毒病大流行前时期)以及2020年3月16日至2021年5月13日(2019冠状病毒病大流行时期)期间,在佩奇临床中心地区癌症中心就诊的18岁及以上HNSCC患者。收集了人口统计学和临床数据,并确定了初始症状出现与首次联系医生之间的时间(TTP)。进行了描述性和探索性统计分析。大流行期间,每月诊断出的HNSCC患者数量平均比2019冠状病毒病大流行前时期减少了12.4%。I期和II期癌症显著增加(分别从15.9%增至20.3%以及从12.2%增至13.8%;p<0.001);III期和IVa、c期癌症减少;大流行期间IVb期癌症显著增加(从6%增至19.9%;p<0.001)。大流行期间,TTP的中位数从43天增加到61天(p=0.032)。据我们所知,这是第一项调查2019冠状病毒病对中东欧地区HNSCC患者影响的研究。我们发现大流行期间癌症分期出现双向变化且TTP增加。我们的研究结果凸显了对2019冠状病毒病影响进行更细致分析的必要性。